chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Nausea
Clinical narrative: chills; headache; aches and pain; feeling nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (headache), MYALGIA (aches and pain) and NAUSEA (feeling nausea) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concomitant products included SIMVASTATIN, ESCITALOPRAM, LEVOTHYROXINE SODIUM (SYNTHROID) and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced CHILLS (chills), HEADACHE (headache), MYALGIA (aches and pain) and NAUSEA (feeling nausea). At the time of the report, CHILLS (chills), HEADACHE (headache), MYALGIA (aches and pain) and NAUSEA (feeling nausea) outcome was unknown. Not Provided          The patient did not receive any treatment.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain in my arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in my arm) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concomitant products included FUROSEMIDE, CARVEDILOL, PRAVASTATIN, FENOFIBRATE, ASPIRIN [ACETYLSALICYLIC ACID], METFORMIN, EMPAGLIFLOZIN (JARDIANCE), DULAGLUTIDE (TRULICITY), LOSARTAN, DIAZEPAM and ZOLPIDEM for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain in my arm). The patient was treated with PARACETAMOL (TYLENOL) for Vaccination site pain, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PAIN (pain in my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included ice. Neither Tylenol nor ice helped.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose decreased
Clinical narrative: Low Blood Sugar; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HYPOGLYCAEMIA (Low Blood Sugar) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concomitant products included SIMVASTATIN, ALFUZOSIN, FUROSEMIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY) and FLUTICASONE for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced HYPOGLYCAEMIA (Low Blood Sugar). At the time of the report, HYPOGLYCAEMIA (Low Blood Sugar) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included K-Tab (10 mg), Trelegy, an Insulin Pump, and vrious Vitamins.  Treatment medication not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypoaesthesia, Lymphadenopathy, Myalgia, Pain in extremity
Clinical narrative: red spot on left hand; white pustules on left hand; painful to touch, left hand; Painful rash on left hand and small rash patch on right hand; Lymph node on underarm on left side swollen; Swollen lymph nodes on both sides of neck; tingling in both hands; Numbness in both hands; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in both hands), LYMPHADENOPATHY (Swollen lymph nodes on both sides of neck), PARAESTHESIA (tingling in both hands), ERYTHEMA (red spot on left hand) and RASH PUSTULAR (white pustules on left hand) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included INTRAUTERINE CONTRACEPTIVE DEVICE for Contraception.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (Body aches). On 13-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness in both hands) and PARAESTHESIA (tingling in both hands). On 14-Feb-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes on both sides of neck). On 15-Feb-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Lymph node on underarm on left side swollen). On 19-Feb-2021, the patient experienced ERYTHEMA (red spot on left hand), RASH PUSTULAR (white pustules on left hand), PAIN IN EXTREMITY (painful to touch, left hand) and RASH (Painful rash on left hand and small rash patch on right hand). At the time of the report, HYPOAESTHESIA (Numbness in both hands), LYMPHADENOPATHY (Swollen lymph nodes on both sides of neck), PARAESTHESIA (tingling in both hands), ERYTHEMA (red spot on left hand), RASH PUSTULAR (white pustules on left hand), PAIN IN EXTREMITY (painful to touch, left hand), RASH (Painful rash on left hand and small rash patch on right hand), VACCINATION SITE LYMPHADENOPATHY (Lymph node on underarm on left side swollen) and MYALGIA (Body aches) outcome was unknown.            The patient did not take any treatment.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Rash, Rash pustular, Vaccination site lymphadenopathy
Clinical narrative: red spot on left hand; white pustules on left hand; painful to touch, left hand; Painful rash on left hand and small rash patch on right hand; Lymph node on underarm on left side swollen; Swollen lymph nodes on both sides of neck; tingling in both hands; Numbness in both hands; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in both hands), LYMPHADENOPATHY (Swollen lymph nodes on both sides of neck), PARAESTHESIA (tingling in both hands), ERYTHEMA (red spot on left hand) and RASH PUSTULAR (white pustules on left hand) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included INTRAUTERINE CONTRACEPTIVE DEVICE for Contraception.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (Body aches). On 13-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness in both hands) and PARAESTHESIA (tingling in both hands). On 14-Feb-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes on both sides of neck). On 15-Feb-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Lymph node on underarm on left side swollen). On 19-Feb-2021, the patient experienced ERYTHEMA (red spot on left hand), RASH PUSTULAR (white pustules on left hand), PAIN IN EXTREMITY (painful to touch, left hand) and RASH (Painful rash on left hand and small rash patch on right hand). At the time of the report, HYPOAESTHESIA (Numbness in both hands), LYMPHADENOPATHY (Swollen lymph nodes on both sides of neck), PARAESTHESIA (tingling in both hands), ERYTHEMA (red spot on left hand), RASH PUSTULAR (white pustules on left hand), PAIN IN EXTREMITY (painful to touch, left hand), RASH (Painful rash on left hand and small rash patch on right hand), VACCINATION SITE LYMPHADENOPATHY (Lymph node on underarm on left side swollen) and MYALGIA (Body aches) outcome was unknown.            The patient did not take any treatment.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cough, Polydipsia, Throat clearing
Clinical narrative: continuous coughing; constantly drinking; constantly clearing throat; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (continuous coughing), POLYDIPSIA (constantly drinking) and THROAT CLEARING (constantly clearing throat) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (continuous coughing), POLYDIPSIA (constantly drinking) and THROAT CLEARING (constantly clearing throat). At the time of the report, COUGH (continuous coughing), POLYDIPSIA (constantly drinking) and THROAT CLEARING (constantly clearing throat) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.6 (High) 100.6 temperature and was sent to the Emergency room.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Rash macular, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Achy bones; soreness; Big red blotch at injection site; Itches at the injection site; Rash at the injection site; Burns at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Big red blotch at injection site), BONE PAIN (Achy bones), VACCINATION SITE PRURITUS (Itches at the injection site), VACCINATION SITE PAIN (Burns at the injection site) and VACCINATION SITE PAIN (soreness) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced RASH MACULAR (Big red blotch at injection site), VACCINATION SITE PRURITUS (Itches at the injection site) and VACCINATION SITE PAIN (Burns at the injection site). On an unknown date, the patient experienced BONE PAIN (Achy bones) and VACCINATION SITE PAIN (soreness). At the time of the report, RASH MACULAR (Big red blotch at injection site), BONE PAIN (Achy bones), VACCINATION SITE PRURITUS (Itches at the injection site), VACCINATION SITE PAIN (Burns at the injection site) and VACCINATION SITE PAIN (soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Nausea, Pruritus
Clinical narrative: rash all over body; Itchiness on body; Cold chills; Joint pain; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash all over body), PRURITUS (Itchiness on body), CHILLS (Cold chills), ARTHRALGIA (Joint pain) and NAUSEA (Nausea) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 03-Dec-2020.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced CHILLS (Cold chills), ARTHRALGIA (Joint pain), NAUSEA (Nausea) and HEADACHE (Headache). On 30-Jan-2021, the patient experienced RASH (rash all over body) and PRURITUS (Itchiness on body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash all over and Generalized itching, at a dose of UNK dosage form and NAPROXEN SODIUM (ALEVE) for Rash all over and Generalized itching, at a dose of UNK dosage form. On 02-Feb-2021, CHILLS (Cold chills), ARTHRALGIA (Joint pain), NAUSEA (Nausea) and HEADACHE (Headache) had resolved. At the time of the report, RASH (rash all over body) and PRURITUS (Itchiness on body) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Dec-2020, SARS-CoV-2 test: positive (Positive) positive COVID test on 03-Dec-2020, and went off of quarantine on 22-Dec-2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitants were not reported. The patient mentioned that rash all over body gets inflamed when she is moving around or in the presence of heat. She also mentioned that it would "recced" for few hours after taking Benadryl.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, SARS-CoV-2 test
Clinical narrative: rash all over body; Itchiness on body; Cold chills; Joint pain; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash all over body), PRURITUS (Itchiness on body), CHILLS (Cold chills), ARTHRALGIA (Joint pain) and NAUSEA (Nausea) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 03-Dec-2020.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced CHILLS (Cold chills), ARTHRALGIA (Joint pain), NAUSEA (Nausea) and HEADACHE (Headache). On 30-Jan-2021, the patient experienced RASH (rash all over body) and PRURITUS (Itchiness on body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash all over and Generalized itching, at a dose of UNK dosage form and NAPROXEN SODIUM (ALEVE) for Rash all over and Generalized itching, at a dose of UNK dosage form. On 02-Feb-2021, CHILLS (Cold chills), ARTHRALGIA (Joint pain), NAUSEA (Nausea) and HEADACHE (Headache) had resolved. At the time of the report, RASH (rash all over body) and PRURITUS (Itchiness on body) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Dec-2020, SARS-CoV-2 test: positive (Positive) positive COVID test on 03-Dec-2020, and went off of quarantine on 22-Dec-2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitants were not reported. The patient mentioned that rash all over body gets inflamed when she is moving around or in the presence of heat. She also mentioned that it would "recced" for few hours after taking Benadryl.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: Rash; shingles; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) and HERPES ZOSTER (shingles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history.).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced RASH (Rash) and HERPES ZOSTER (shingles). At the time of the report, RASH (Rash) and HERPES ZOSTER (shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were given  treatment information was provided as Valacyclovir
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore right arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore right arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concomitant products included IBANDRONATE SODIUM (BONIVA) for Bone density abnormal.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore right arm). At the time of the report, VACCINATION SITE PAIN (Sore right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not receive any treatment medication.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Oral mucosal erythema, Stomatitis, Vaccination complication, Vaccination site mass
Clinical narrative: Big Hard Red Knot at injection site; Knot at injection site was hot; Felt Bad; No Energy; Mouth was red; Irritated Mouth; Knot at injection site was itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Big Hard Red Knot at injection site), VACCINATION SITE WARMTH (Knot at injection site was hot), VACCINATION COMPLICATION (Felt Bad), ASTHENIA (No Energy) and ORAL MUCOSAL ERYTHEMA (Mouth was red) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to sting (Yellow sting allergy.) and Allergy to vaccine (allergy shots she receives for yellow jacket sting allergy.).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE MASS (Big Hard Red Knot at injection site), VACCINATION SITE WARMTH (Knot at injection site was hot), VACCINATION COMPLICATION (Felt Bad), ASTHENIA (No Energy), ORAL MUCOSAL ERYTHEMA (Mouth was red), STOMATITIS (Irritated Mouth) and VACCINATION SITE PRURITUS (Knot at injection site was itchy). At the time of the report, VACCINATION SITE MASS (Big Hard Red Knot at injection site), VACCINATION SITE WARMTH (Knot at injection site was hot), VACCINATION COMPLICATION (Felt Bad), ASTHENIA (No Energy), ORAL MUCOSAL ERYTHEMA (Mouth was red), STOMATITIS (Irritated Mouth) and VACCINATION SITE PRURITUS (Knot at injection site was itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medication was not provided.  The patient was scheduled to get second shot on 19-Feb-2021.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Big Hard Red Knot at injection site; Knot at injection site was hot; Felt Bad; No Energy; Mouth was red; Irritated Mouth; Knot at injection site was itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Big Hard Red Knot at injection site), VACCINATION SITE WARMTH (Knot at injection site was hot), VACCINATION COMPLICATION (Felt Bad), ASTHENIA (No Energy) and ORAL MUCOSAL ERYTHEMA (Mouth was red) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to sting (Yellow sting allergy.) and Allergy to vaccine (allergy shots she receives for yellow jacket sting allergy.).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE MASS (Big Hard Red Knot at injection site), VACCINATION SITE WARMTH (Knot at injection site was hot), VACCINATION COMPLICATION (Felt Bad), ASTHENIA (No Energy), ORAL MUCOSAL ERYTHEMA (Mouth was red), STOMATITIS (Irritated Mouth) and VACCINATION SITE PRURITUS (Knot at injection site was itchy). At the time of the report, VACCINATION SITE MASS (Big Hard Red Knot at injection site), VACCINATION SITE WARMTH (Knot at injection site was hot), VACCINATION COMPLICATION (Felt Bad), ASTHENIA (No Energy), ORAL MUCOSAL ERYTHEMA (Mouth was red), STOMATITIS (Irritated Mouth) and VACCINATION SITE PRURITUS (Knot at injection site was itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medication was not provided.  The patient was scheduled to get second shot on 19-Feb-2021.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site discolouration
Clinical narrative: Black spot on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOLOURATION (Black spot on the injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE DISCOLOURATION (Black spot on the injection site). At the time of the report, INJECTION SITE DISCOLOURATION (Black spot on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication was reported. No treatment drug was reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site vesicles
Clinical narrative: blood blister at injection site; terible itching; red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE VESICLES (blood blister at injection site), VACCINATION SITE PRURITUS (terible itching) and VACCINATION SITE ERYTHEMA (red at injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE VESICLES (blood blister at injection site), VACCINATION SITE PRURITUS (terible itching) and VACCINATION SITE ERYTHEMA (red at injection site). At the time of the report, VACCINATION SITE VESICLES (blood blister at injection site), VACCINATION SITE PRURITUS (terible itching) and VACCINATION SITE ERYTHEMA (red at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were Thyroid meds, Acid reflux for drug use for unknown indication. No treatment medication information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Rectal tenesmus, Vision blurred
Clinical narrative: feeling urgency for bowl movement; blurry vision; feeling like going to throw up; This spontaneous case was reported by a consumer and describes the occurrence of RECTAL TENESMUS (feeling urgency for bowl movement), VISION BLURRED (blurry vision) and NAUSEA (feeling like going to throw up) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included Vertigo. Concomitant products included ROSUVASTATIN CALCIUM (IBSTATIN) for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced RECTAL TENESMUS (feeling urgency for bowl movement), VISION BLURRED (blurry vision) and NAUSEA (feeling like going to throw up). At the time of the report, RECTAL TENESMUS (feeling urgency for bowl movement), VISION BLURRED (blurry vision) and NAUSEA (feeling like going to throw up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications included antiseizure for vertigo and allergy medication 125 mg. Treatment medications included antacid and diphenhydramine. The patient received diphenhydramine on 01-Feb-2021 and 02-Feb-2021.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site pian; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site pian) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included PARACETAMOL (TYLENOL) for Arthritis.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (injection site pian). At the time of the report, VACCINATION SITE PAIN (injection site pian) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not reported.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea, Pyrexia, Vomiting
Clinical narrative: diarrhea; vomiting; fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), VOMITING (vomiting) and PYREXIA (fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043l20a) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), VOMITING (vomiting) and PYREXIA (fever). At the time of the report, DIARRHOEA (diarrhea), VOMITING (vomiting) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Headache, Hyperhidrosis
Clinical narrative: sore throat; cough; night sweats; skin feeling like it was on fire; Arm hurt really bad; chills; low grade fever of 99-100F; sweating; Scratchy throat; headache; fatigue; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), COUGH (cough), NIGHT SWEATS (night sweats), SKIN BURNING SENSATION (skin feeling like it was on fire) and PAIN IN EXTREMITY (Arm hurt really bad) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 from 20-Dec-2020 to 30-Dec-2020. Concurrent medical conditions included Gluten sensitivity and Milk allergy. Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]) for Blood pressure abnormal, ALPRAZOLAM (LAMPRO) for Mood altered, LEVOTHYROXINE and THYROID (ARMOUR THYROID) for Thyroid disorder NOS, LAMOTRIGINE for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HYPERHIDROSIS (sweating), THROAT IRRITATION (Scratchy throat), HEADACHE (headache) and FATIGUE (fatigue). On 21-Jan-2021 at 12:00 PM, the patient experienced OROPHARYNGEAL PAIN (sore throat), COUGH (cough), NIGHT SWEATS (night sweats), SKIN BURNING SENSATION (skin feeling like it was on fire), PAIN IN EXTREMITY (Arm hurt really bad), CHILLS (chills) and PYREXIA (low grade fever of 99-100F). On 24-Jan-2021, OROPHARYNGEAL PAIN (sore throat), COUGH (cough), NIGHT SWEATS (night sweats), SKIN BURNING SENSATION (skin feeling like it was on fire), PAIN IN EXTREMITY (Arm hurt really bad), HYPERHIDROSIS (sweating), THROAT IRRITATION (Scratchy throat), HEADACHE (headache), FATIGUE (fatigue), CHILLS (chills) and PYREXIA (low grade fever of 99-100F) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Within one hour of receiving vaccine, the patient experienced cough and scratchy throat, by 3 pm the patient experienced chills. At 6 pm, chills turned into low grade fever. The patient's arm hurt really bad. Fatigue with sweating persisted for the next day. On 24-Jan-2021, all the symptoms were resolved.   This case was linked to MOD-2021-065097 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: additional events of arm hurt really bad, scratchy throat added, outcome of events changed to resolved, first dose date changed, event onset dates changed as per follow up received; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Night sweats, Oropharyngeal pain, Pain in extremity, Pyrexia, Skin burning sensation
Clinical narrative: sore throat; cough; night sweats; skin feeling like it was on fire; Arm hurt really bad; chills; low grade fever of 99-100F; sweating; Scratchy throat; headache; fatigue; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), COUGH (cough), NIGHT SWEATS (night sweats), SKIN BURNING SENSATION (skin feeling like it was on fire) and PAIN IN EXTREMITY (Arm hurt really bad) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 from 20-Dec-2020 to 30-Dec-2020. Concurrent medical conditions included Gluten sensitivity and Milk allergy. Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]) for Blood pressure abnormal, ALPRAZOLAM (LAMPRO) for Mood altered, LEVOTHYROXINE and THYROID (ARMOUR THYROID) for Thyroid disorder NOS, LAMOTRIGINE for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HYPERHIDROSIS (sweating), THROAT IRRITATION (Scratchy throat), HEADACHE (headache) and FATIGUE (fatigue). On 21-Jan-2021 at 12:00 PM, the patient experienced OROPHARYNGEAL PAIN (sore throat), COUGH (cough), NIGHT SWEATS (night sweats), SKIN BURNING SENSATION (skin feeling like it was on fire), PAIN IN EXTREMITY (Arm hurt really bad), CHILLS (chills) and PYREXIA (low grade fever of 99-100F). On 24-Jan-2021, OROPHARYNGEAL PAIN (sore throat), COUGH (cough), NIGHT SWEATS (night sweats), SKIN BURNING SENSATION (skin feeling like it was on fire), PAIN IN EXTREMITY (Arm hurt really bad), HYPERHIDROSIS (sweating), THROAT IRRITATION (Scratchy throat), HEADACHE (headache), FATIGUE (fatigue), CHILLS (chills) and PYREXIA (low grade fever of 99-100F) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Within one hour of receiving vaccine, the patient experienced cough and scratchy throat, by 3 pm the patient experienced chills. At 6 pm, chills turned into low grade fever. The patient's arm hurt really bad. Fatigue with sweating persisted for the next day. On 24-Jan-2021, all the symptoms were resolved.   This case was linked to MOD-2021-065097 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: additional events of arm hurt really bad, scratchy throat added, outcome of events changed to resolved, first dose date changed, event onset dates changed as per follow up received; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: sore throat; cough; night sweats; skin feeling like it was on fire; Arm hurt really bad; chills; low grade fever of 99-100F; sweating; Scratchy throat; headache; fatigue; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), COUGH (cough), NIGHT SWEATS (night sweats), SKIN BURNING SENSATION (skin feeling like it was on fire) and PAIN IN EXTREMITY (Arm hurt really bad) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 from 20-Dec-2020 to 30-Dec-2020. Concurrent medical conditions included Gluten sensitivity and Milk allergy. Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]) for Blood pressure abnormal, ALPRAZOLAM (LAMPRO) for Mood altered, LEVOTHYROXINE and THYROID (ARMOUR THYROID) for Thyroid disorder NOS, LAMOTRIGINE for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HYPERHIDROSIS (sweating), THROAT IRRITATION (Scratchy throat), HEADACHE (headache) and FATIGUE (fatigue). On 21-Jan-2021 at 12:00 PM, the patient experienced OROPHARYNGEAL PAIN (sore throat), COUGH (cough), NIGHT SWEATS (night sweats), SKIN BURNING SENSATION (skin feeling like it was on fire), PAIN IN EXTREMITY (Arm hurt really bad), CHILLS (chills) and PYREXIA (low grade fever of 99-100F). On 24-Jan-2021, OROPHARYNGEAL PAIN (sore throat), COUGH (cough), NIGHT SWEATS (night sweats), SKIN BURNING SENSATION (skin feeling like it was on fire), PAIN IN EXTREMITY (Arm hurt really bad), HYPERHIDROSIS (sweating), THROAT IRRITATION (Scratchy throat), HEADACHE (headache), FATIGUE (fatigue), CHILLS (chills) and PYREXIA (low grade fever of 99-100F) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Within one hour of receiving vaccine, the patient experienced cough and scratchy throat, by 3 pm the patient experienced chills. At 6 pm, chills turned into low grade fever. The patient's arm hurt really bad. Fatigue with sweating persisted for the next day. On 24-Jan-2021, all the symptoms were resolved.   This case was linked to MOD-2021-065097 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: additional events of arm hurt really bad, scratchy throat added, outcome of events changed to resolved, first dose date changed, event onset dates changed as per follow up received; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Swollen and red; Injection site was itchy and Red; Injection site was itchy and Red; Injected arm was a little Sore; A spontaneous report was received from a consumer concerning a 78-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced injected arm was a little sore/vaccination site pain, arm at the injection site was itchy/accination site pruritus and red/vaccination site erythema, injection site was swollen/ vaccination site swelling and red/vaccination site erythema.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 23 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch Number: 029L20A) intramuscularly in the upper arm for prophylaxis of COVID-19 infection.  On 23 Jan 2021, first day the patient experienced injected arm was a little Sore. On 30 Jan 2021 Saturday, the patient experienced arm at the injection site was itchy and red. On 31 Jan 2021 Sunday morning, the patient experienced injection site was not itching. On 31 Jan 2021 Sunday afternoon, the patient experienced injection site was itching, swollen and red. On 01 Feb 2021, the patient experienced injection site looks a lighter red, but the light red area was big 3.5x2 inch.  Treatment details included diphenhydramine topical  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, injected arm was a little sore was resolved on 24 Jan 2021. The outcome of events, arm at the injection site was itchy and red, injection site was swollen and red, light red area was big 3.5x2 inch was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives all over the body; A spontaneous report was received from a Consumer concerning a unknown age female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events, hives all over the body after receiving the first dose of moderna covid-19 vaccine on January.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 6 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events, Hives all over the body after receiving the first dose of Moderna COVID-19 Vaccine.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events, hives all over the body after receiving the first dose of Moderna covid-19 vaccine was not reported.   On an unknown date the outcome of events include, hives all over the body after receiving the first dose of Moderna covid-19 vaccine was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itch at the injection site; a little hard at injection site; 3in circle that was red at injection site; swelling at the inejction site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itch at the injection site), VACCINATION SITE INDURATION (a little hard at injection site), VACCINATION SITE ERYTHEMA (3in circle that was red at injection site) and VACCINATION SITE SWELLING (swelling at the inejction site) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itch at the injection site), VACCINATION SITE INDURATION (a little hard at injection site), VACCINATION SITE ERYTHEMA (3in circle that was red at injection site) and VACCINATION SITE SWELLING (swelling at the inejction site). At the time of the report, VACCINATION SITE PRURITUS (itch at the injection site), VACCINATION SITE INDURATION (a little hard at injection site), VACCINATION SITE ERYTHEMA (3in circle that was red at injection site) and VACCINATION SITE SWELLING (swelling at the inejction site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. The patient did not take any treatment medication.  After getting the vaccine the patient underwent a colonoscopy.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Fatigue, Nausea, Pain in extremity
Clinical narrative: 2 nosebleeds within an hour; Arm is hurting; Nausea; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (2 nosebleeds within an hour), PAIN IN EXTREMITY (Arm is hurting), NAUSEA (Nausea) and FATIGUE (Tiredness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concomitant products included GLIPIZIDE, LISINOPRIL, ASPIRIN [ACETYLSALICYLIC ACID], CALCIUM and PANTOPRAZOLE for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced EPISTAXIS (2 nosebleeds within an hour), PAIN IN EXTREMITY (Arm is hurting), NAUSEA (Nausea) and FATIGUE (Tiredness). At the time of the report, EPISTAXIS (2 nosebleeds within an hour), PAIN IN EXTREMITY (Arm is hurting), NAUSEA (Nausea) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   2-3 hours after receiving the vaccine, the patient experienced a severe nosebleed. 45 minutes later she had another episode of nosebleed. She states that it was running like water and filled up the whole bathroom sink.   No treatment information was provided.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: Redness at the injection site; COVID arm; Itching close to the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching close to the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching close to the injection site). On 30-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site pruritus and Vaccination site erythema, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PRURITUS (Itching close to the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  Then on Saturday, January 30th and Sunday 31st it was a larger area of redness and itching.
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Rash on his stomach and it has red bumps; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH ERYTHEMATOUS (Rash on his stomach and it has red bumps) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced RASH ERYTHEMATOUS (Rash on his stomach and it has red bumps). The patient was treated with TRIAMCINOLONE (topical) for Rash, at a dose of 1 %. At the time of the report, RASH ERYTHEMATOUS (Rash on his stomach and it has red bumps) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.    Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Significant Follow-up received on 26-May-2021.Updated outcome for the rash to not resolved
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Vaccination site erythema
Clinical narrative: red/itchy rash at the injection; red/itchy rash at the injection; rash in the right arm; chills; Fatigue; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (red/itchy rash at the injection), CHILLS (chills), FATIGUE (Fatigue), HEADACHE (Headache) and NAUSEA (Nausea) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007N2OA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced CHILLS (chills), FATIGUE (Fatigue), HEADACHE (Headache) and NAUSEA (Nausea). On 03-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (red/itchy rash at the injection), VACCINATION SITE ERYTHEMA (red/itchy rash at the injection) and VACCINATION SITE RASH (rash in the right arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (red/itchy rash at the injection), CHILLS (chills), FATIGUE (Fatigue), HEADACHE (Headache), NAUSEA (Nausea), VACCINATION SITE ERYTHEMA (red/itchy rash at the injection) and VACCINATION SITE RASH (rash in the right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.    Reporter did not allow further contact